ATMIN
Basic information
Region (hg38): 16:81035842-81047350
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATMIN gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 56 | 63 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 0 | 57 | 8 | 0 |
Variants in ATMIN
This is a list of pathogenic ClinVar variants found in the ATMIN region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
16-81035878-C-G | not specified | Uncertain significance (Feb 17, 2022) | ||
16-81035896-C-T | not specified | Uncertain significance (Oct 27, 2022) | ||
16-81035899-C-A | not specified | Uncertain significance (Feb 10, 2023) | ||
16-81035917-C-T | not specified | Uncertain significance (Feb 22, 2023) | ||
16-81035926-C-G | not specified | Uncertain significance (Aug 16, 2022) | ||
16-81035937-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
16-81035938-C-T | not specified | Uncertain significance (Oct 26, 2022) | ||
16-81035941-C-T | not specified | Likely benign (Dec 05, 2022) | ||
16-81036013-G-A | not specified | Uncertain significance (Sep 30, 2021) | ||
16-81036066-G-A | not specified | Likely benign (Aug 16, 2021) | ||
16-81036131-C-T | Likely benign (Oct 01, 2022) | |||
16-81036165-C-T | not specified | Uncertain significance (Mar 06, 2023) | ||
16-81041360-G-A | not specified | Uncertain significance (Aug 20, 2023) | ||
16-81041364-A-G | not specified | Uncertain significance (Nov 03, 2023) | ||
16-81041407-T-G | not specified | Uncertain significance (Dec 26, 2023) | ||
16-81042312-A-G | not specified | Uncertain significance (Feb 12, 2024) | ||
16-81042321-G-C | not specified | Uncertain significance (Jan 07, 2022) | ||
16-81042324-A-G | not specified | Uncertain significance (Jun 21, 2023) | ||
16-81042393-G-A | not specified | Likely benign (Aug 02, 2023) | ||
16-81042401-T-C | not specified | Uncertain significance (Sep 29, 2023) | ||
16-81042401-T-G | not specified | Uncertain significance (Mar 25, 2024) | ||
16-81042461-G-A | not specified | Uncertain significance (Aug 18, 2021) | ||
16-81043163-A-T | not specified | Uncertain significance (Sep 06, 2022) | ||
16-81043220-A-G | not specified | Likely benign (Apr 25, 2022) | ||
16-81043238-T-C | not specified | Uncertain significance (Apr 22, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATMIN | protein_coding | protein_coding | ENST00000299575 | 4 | 11512 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000503 | 0.993 | 125702 | 0 | 45 | 125747 | 0.000179 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.735 | 451 | 409 | 1.10 | 0.0000205 | 5380 |
Missense in Polyphen | 92 | 98.084 | 0.93797 | 1361 | ||
Synonymous | -2.16 | 199 | 164 | 1.22 | 0.00000968 | 1679 |
Loss of Function | 2.40 | 11 | 23.6 | 0.466 | 0.00000109 | 309 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000400 | 0.000399 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.000109 | 0.000109 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.0000968 | 0.0000967 |
Middle Eastern | 0.000109 | 0.000109 |
South Asian | 0.000621 | 0.000621 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Transcription factor. Plays a crucial role in cell survival and RAD51 foci formation in response to methylating DNA damage. Involved in regulating the activity of ATM in the absence of DNA damage. May play a role in stabilizing ATM. Binds to the DYNLL1 promoter and activates its transcription. {ECO:0000269|PubMed:15933716, ECO:0000269|PubMed:17525732, ECO:0000269|PubMed:22167198}.;
- Pathway
- ATM Signaling Network in Development and Disease
(Consensus)
Recessive Scores
- pRec
- 0.110
Intolerance Scores
- loftool
- 0.652
- rvis_EVS
- -0.88
- rvis_percentile_EVS
- 10.5
Haploinsufficiency Scores
- pHI
- 0.579
- hipred
- Y
- hipred_score
- 0.608
- ghis
- 0.619
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.252
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atmin
- Phenotype
- homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); neoplasm; hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype;
Gene ontology
- Biological process
- cellular response to DNA damage stimulus;motile cilium assembly;positive regulation of transcription, DNA-templated;positive regulation of non-motile cilium assembly
- Cellular component
- nuclear body
- Molecular function
- protein binding;transcription regulatory region DNA binding;metal ion binding;dynein complex binding